Charles River Laboratories | CRL - Marktkapitalisierung

Aktienkurs
169.80
Täglich Wechseln
2.06 1.23%
Monatlich
2.36%
Jährlich
48.09%
Q2 Prognose
166.17




Marktkapitalisierung Veränderung Datum
Agilent USD 37.86B 3.64B 2025-12
Align Technology USD 11.2B 2.13B 2025-12
Bio-Rad Laboratories USD 8.21B 601M 2025-12
Bruker USD 7.16B 2.23B 2025-12
Cardinal Health USD 48.83B 11.54B 2025-12
Charles River Laboratories USD 10.02B 2.71B 2025-12
Cigna USD 73.52B 3.42B 2025-12
Concord Medical Services Hldg CNY 166.72M 11.49M 2026-04
CVS Health USD 100.74B 5.12B 2025-12
Danaher USD 140.45B 11.98B 2026-04
Dentsply International USD 2.28B 251M 2025-12
Elevance Health USD 76.12B 11.81B 2026-04
Galapagos EUR 1.85B 76.44M 2025-12
Humana USD 30.81B 485M 2025-12
Illumina USD 20.62B 6.53B 2025-12
Incyte USD 19.39B 2.83B 2025-12
IQVIA Holdings USD 29.18B 9.2B 2026-04
Laboratory Of America USD 20.8B 3.03B 2025-12
Lonza CHF 39.68B 980.61M 2025-06
McKesson USD 101.25B 5.15B 2025-12
Merck EUR 53.3B 5.72B 2025-12
Mettler Toledo International USD 28.48B 3.19B 2025-12
Novartis USD 292.21B 26.55B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Quest Diagnostics USD 22.89B 1.19B 2026-04
Revvity USD 10.97B 1.21B 2025-12
Thermo Fisher Scientific USD 177.96B 4.7B 2026-04
United Therapeutics USD 20.98B 2.02B 2025-12
UnitedHealth USD 319B 73.39B 2026-04
Veradigm USD 525M 621M 2026-03
Waters USD 22.61B 5.25B 2025-12
West Pharmaceutical Services USD 22.67B 4.61B 2026-04